György Túrós

Title: György Túrós: Innovator in Pharmaceutical Compounds

Introduction

György Túrós is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating various diseases. His work focuses on inhibiting semicarbazide-sensitive amine oxidase (SSAO), also known as vascular adhesion protein-1 (VAP-1).

Latest Patents

György Túrós holds a patent for "Compounds for inhibiting semicarbazide-sensitive amine oxidase (SSAO)/vascular adhesion protein-1 (VAP-1) and uses thereof for treatment and prevention of diseases." This invention relates to compounds of general formula (i) that possess an oxime moiety or a pharmaceutically acceptable salt, hydrate, or solvate. The patent outlines the use of these compounds in preventing or treating diseases associated with SSAO/VAP-1, including inflammatory diseases, diabetes-related complications, and neurodegenerative conditions. He has 1 patent to his name.

Career Highlights

Throughout his career, György Túrós has worked with prestigious institutions such as Semmelweis University and the University of Pécs. His research has significantly advanced the understanding of SSAO/VAP-1 and its implications in various medical conditions.

Collaborations

György Túrós has collaborated with notable colleagues, including Péter Mátyus and Kálmán Magyar. Their joint efforts have contributed to the development of innovative solutions in the pharmaceutical field.

Conclusion

György Túrós is a distinguished inventor whose work in pharmaceutical compounds has the potential to impact the treatment of several diseases. His contributions to the field are noteworthy and reflect his commitment to advancing medical science.